Health Cor Management, L.P. Rapt Therapeutics, Inc. Transaction History

Health Cor Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$10.26 - $23.59 $482,066 - $1.11 Million	-46,985 Reduced 17.79%	217,165 $3.96 Million
Q1 2022 May 16, 2022	BUY	$17.02 - $40.22 $1.41 Million - $3.33 Million	82,750 Added 45.62%	264,150 $5.81 Million
Q4 2021 Feb 14, 2022	SELL	$29.5 - $39.5 $97,350 - $130,350	-3,300 Reduced 1.79%	181,400 $6.66 Million
Q3 2021 Nov 15, 2021	SELL	$29.86 - $39.47 $456,858 - $603,891	-15,300 Reduced 7.65%	184,700 $5.74 Million
Q2 2021 Aug 16, 2021	BUY	$17.99 - $40.02 $3.6 Million - $8 Million	200,000 New	200,000 $6.36 Million

104

27.1M

26.7K

2.4K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $26.1M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.